Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

16.98 -0.66 (-3.77%)
Streaming Delayed Price Updated: 11:37 AM EST, Jan 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Beta Bionics, Inc. - Common Stock

News headline image
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
Securities Fraud Investigation Into Beta Bionics, Inc. (BBNX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Beta Bionics, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – BBNX
From DJS Law Group
Via Business Wire
News headline image
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics Announces Participation at Upcoming Investor Conferences
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics Announces Participation at Upcoming Investor Conferences
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics to Present at the Bank of America Securities Health Care Conference
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics to Host Investor Event on June 22, 2025
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics Announces Board Appointment of Gerard Michel
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Beta Bionics, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.